ATE81345T1 - Synthetische atriale peptide. - Google Patents

Synthetische atriale peptide.

Info

Publication number
ATE81345T1
ATE81345T1 AT87870038T AT87870038T ATE81345T1 AT E81345 T1 ATE81345 T1 AT E81345T1 AT 87870038 T AT87870038 T AT 87870038T AT 87870038 T AT87870038 T AT 87870038T AT E81345 T1 ATE81345 T1 AT E81345T1
Authority
AT
Austria
Prior art keywords
atrial peptides
synthetic atrial
ser
synthetic
peptides
Prior art date
Application number
AT87870038T
Other languages
English (en)
Inventor
Foe Siong Tjoeng
Kam Fook Fok
Paul Steven Adams
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ATE81345T1 publication Critical patent/ATE81345T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C07K14/582—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT87870038T 1986-03-27 1987-03-26 Synthetische atriale peptide. ATE81345T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/844,906 US4716147A (en) 1986-03-27 1986-03-27 Synthetic airial peptides
EP87870038A EP0239558B1 (de) 1986-03-27 1987-03-26 Synthetische atriale Peptide

Publications (1)

Publication Number Publication Date
ATE81345T1 true ATE81345T1 (de) 1992-10-15

Family

ID=25293931

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87870038T ATE81345T1 (de) 1986-03-27 1987-03-26 Synthetische atriale peptide.

Country Status (6)

Country Link
US (1) US4716147A (de)
EP (1) EP0239558B1 (de)
JP (1) JPS62240699A (de)
AT (1) ATE81345T1 (de)
AU (1) AU595592B2 (de)
DE (1) DE3782073T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212286A (en) * 1984-04-19 1993-05-18 Scios Nova Inc. Atrial natriuretic/vasodilator peptide compounds
US5057603A (en) * 1986-01-31 1991-10-15 Merck & Co., Inc. Peptides having ANF activity
EP0246795A3 (de) * 1986-05-20 1990-04-04 Advanced Peptide Development Limited Synthetische natriuretische Peptide
US5565606A (en) * 1986-10-21 1996-10-15 Hoechst Aktiengesellschaft Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
DE3723551A1 (de) * 1987-07-16 1989-01-26 Hoechst Ag Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DK531986D0 (da) * 1986-11-07 1986-11-07 Novo Industri As Peptider
US4859736A (en) * 1987-03-30 1989-08-22 Ciba-Geigy Corporation Synthetic polystyrene resin and its use in solid phase peptide synthesis
US4816443A (en) * 1987-05-19 1989-03-28 Merck & Co., Inc. Piptides having ANF activity
ATE90108T1 (de) * 1987-10-09 1993-06-15 Takeda Chemical Industries Ltd Vasokonstriktor-peptid.
US5262521A (en) * 1991-06-07 1993-11-16 Sri International Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
AU2007233123A1 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
AU2007233116B2 (en) * 2006-03-30 2013-05-09 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8436140B2 (en) * 2008-06-02 2013-05-07 Washington University Natriuretic peptide-mediated imaging of atherosclerotic plaque

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496544A (en) * 1983-11-10 1985-01-29 Washington University Atrial Peptides
US4508712A (en) * 1984-01-10 1985-04-02 Washington University Atrial peptide
US4952561A (en) * 1984-02-07 1990-08-28 Merck & Co., Inc. Cardiac atrial peptides
JPH0672157B2 (ja) * 1984-08-29 1994-09-14 味の素株式会社 新規ペプチド

Also Published As

Publication number Publication date
JPS62240699A (ja) 1987-10-21
DE3782073D1 (en) 1992-11-12
EP0239558A2 (de) 1987-09-30
EP0239558A3 (en) 1990-01-03
EP0239558B1 (de) 1992-10-07
AU7066087A (en) 1987-10-01
DE3782073T2 (de) 1993-05-06
US4716147A (en) 1987-12-29
AU595592B2 (en) 1990-04-05

Similar Documents

Publication Publication Date Title
DE3782073D1 (en) Synthetische atriale peptide.
IE842881L (en) Atrial peptides
ATE108459T1 (de) Antagonisten des fibroblasten-wachstumsfaktors.
FI921740L (fi) Hybrid polypeptid
EP0500108A3 (en) Improved activation of recombinant proteins
DE3885313D1 (de) Peptide mit Laminin-Wirksamkeit.
ES2124247T3 (es) Conjugado de calcitonina y de polietilenglicol.
ES2157523T3 (es) Solucion de dialisis peritoneal.
FI885296L (fi) Rekombinant hiv-2 polypeptid.
NO902871D0 (no) Fremgangsmaate for innfoering av et peptid i cytosol.
DE69313647D1 (de) Synthetische peptide als lungensurfactants mit kovalent gebundenen antioxidantien
MX9304540A (es) Tensioactivos pulmonares peptidicos y combinaciones terapeuticas.
FI900075L (fi) Medvaexthormon bindande peptid.
ATE98962T1 (de) Menschliche rhinoviruspeptide.
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE315646T1 (de) Leukocyten-aktivierender faktor
DE69010750D1 (de) Antikörper gegen Fibrin, immunogene Peptide für die Herstellung dieser Antikörper, Verfahren zur Bestimmung von Fibrin und pharmazeutische Zubereitungen auf der Basis dieser Antikörper.
ES2061585T3 (es) Señal de secrecion de bar1.
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
ES2080326T3 (es) Proteinas similares a ancrod, su obtencion y empleo.
DE69613086D1 (de) Antigenen Peptide mit Glycinsubstitution
PT84798B (de) Cyclische peptide mit cytoprotektiver wirkung
IT219462Z2 (it) Struttura di calza in particolare di tipo sportivo,con mezzi atti al suo trattenimento lungo la gamba dell'utente
FI904679A7 (fi) Peptidit, joissa on sulfaattiesteriryhmiä
IE891123L (en) Preparing proteins which start with n-terminal proline

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee